Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis
The demonstrated effectiveness and safety of our nanosystem therapy highlights a promising therapeutic approach for PDAC, showcasing its potential in reprogramming TAMs and mitigating the occurrence of liver metastasis.
Authors
- Adrián Palencia‐Campos (ORCID: https://orcid.org/0000-0001-7440-0347)
- Diego Navarro (ORCID: https://orcid.org/0000-0003-4246-5327)
- Sonia Alcalá (ORCID: https://orcid.org/0000-0002-7644-4973)
- Laura Sánchez (ORCID: https://orcid.org/0000-0001-7927-5303)
- Bruno Sáinz (ORCID: https://orcid.org/0000-0003-4829-7651)
- Simona Mura (ORCID: https://orcid.org/0000-0003-0310-8052)
- Nadège Bidan
- Laura Ruíz-Cañas (ORCID: https://orcid.org/0000-0002-4373-2573)
- Juan A. Rubiolo (ORCID: https://orcid.org/0000-0002-7820-7365)
- Juan Carlos López-Gil (ORCID: https://orcid.org/0000-0003-4988-8648)
- Sofia M. Saraiva (ORCID: https://orcid.org/0000-0001-8849-804X)
- Patrick Hermann (ORCID: https://orcid.org/0000-0003-0418-0478)
- María de la Fuente (ORCID: https://orcid.org/0000-0003-0322-1469)
- Balbino Yagüe
- Sandra Batres-Ramos
- Marcelina Abal-Sanisidro (ORCID: https://orcid.org/0000-0002-4132-906X)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Universität Ulm (DE)
- Universidade de Santiago de Compostela (ES)
- Université Paris-Saclay (FR)
- Instituto de Salud Carlos III (ES)
- National University of Rosario (AR)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1186/s12951-024-03010-5
- Citations
- 6
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.44
Funders
- “la Caixa” Foundation
- Comunidad de Madrid
- EuroNanoMed III
- Universidad Autónoma de Madrid
- Deutsche Krebshilfe
- Consejo Superior de Investigaciones Científicas
- Instituto de Salud Carlos III
- European Regional Development Fund
- H2020 European Research Council